Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro
The combination of photodynamic agents and biological inhibitors is rapidly gaining attention for its promise and approval in treating advanced cancer. The activity of photodynamic treatment is mainly governed by the formation of reactive oxygen species upon light activation of photosensitizers. Exp...
Main Authors: | Aaron J. Sorrin, Cindy Liu, Julia Cicalo, Jocelyn Reader, Daniel Najafali, Yuji Zhang, Dana M. Roque, Huang-Chiao Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/21/5259 |
Similar Items
-
Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids
by: Aaron Sorrin, et al.
Published: (2024-02-01) -
Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Cell Monolayer and Multicellular Tumor Spheroid Models
by: Mouldy Sioud, et al.
Published: (2021-07-01) -
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy
by: Yan Baglo, et al.
Published: (2021-11-01) -
Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives
by: Masaki Kuwatani, et al.
Published: (2023-07-01) -
Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy
by: Xiaoxia Cheng, et al.
Published: (2022-11-01)